[KTTA] YoY Quarter Result on 30-Jun-2022 [#Q2]

Stock
[KTTA] Pasithea Therapeutics Corp.
Announcement Date
15-Aug-2022
Financial Year
2022
Quarter
30-Jun-2022 [#Q2]
Profit Trend
QoQ- -4,526.83%
YoY- -149.31%
Quarter Report
KTTA's Result
KTTA's Financial Summary
View:
Show?
Quarter Result
30/06/24 30/06/23 30/06/22 30/06/21 CAGR
Revenue 0 0 14 0 -
PBT -3,866 -3,598 -2,658 -728 74.37%
Tax 0 -65 -843 0 -
NP -3,866 -3,763 -1,815 -728 74.37%
Tax Rate - - - - -
Total Cost 3,866 3,763 1,829 728 74.37%
Ratio Analysis
30/06/24 30/06/23 30/06/22 30/06/21 CAGR
NP Margin 0.00 0.00 -13,364.21 0.00 -
Per Share
30/06/24 30/06/23 30/06/22 30/06/21 CAGR
EPS -3.71 -2.88 -0.08 -0.07 275.17%
EPS Diluted -3.71 -2.88 -0.08 -0.07 275.17%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.